PortfoliosLab logoPortfoliosLab logo
CSPCY vs. ^GSPC
Performance
Return for Risk
Drawdowns
Volatility

Performance

CSPCY vs. ^GSPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CSPC Pharmaceutical Group Limited (CSPCY) and S&P 500 Index (^GSPC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CSPCY achieves a -18.93% return, which is significantly lower than ^GSPC's 7.49% return.


CSPCY

1D
1.57%
1M
-11.09%
YTD
-18.93%
6M
-20.72%
1Y
-14.08%
3Y*
5.84%
5Y*
-6.77%
10Y*

^GSPC

1D
-0.10%
1M
-1.54%
YTD
7.49%
6M
6.15%
1Y
20.78%
3Y*
19.17%
5Y*
11.44%
10Y*
13.70%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CSPCY vs. ^GSPC - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
CSPCY
CSPC Pharmaceutical Group Limited
-18.93%88.02%-31.60%-5.79%-2.57%10.40%-40.15%85.31%
^GSPC
S&P 500 Index
7.49%16.39%23.31%24.23%-19.44%26.89%16.26%11.69%

Correlation

The correlation between CSPCY and ^GSPC is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Apr 8, 2019

0.13

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CSPCY vs. ^GSPC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CSPCY
CSPCY Risk / Return Rank: 3232
Overall Rank
CSPCY Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
CSPCY Sortino Ratio Rank: 3232
Sortino Ratio Rank
CSPCY Omega Ratio Rank: 3232
Omega Ratio Rank
CSPCY Calmar Ratio Rank: 3232
Calmar Ratio Rank
CSPCY Martin Ratio Rank: 3131
Martin Ratio Rank

^GSPC
^GSPC Risk / Return Rank: 6060
Overall Rank
^GSPC Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
^GSPC Sortino Ratio Rank: 5656
Sortino Ratio Rank
^GSPC Omega Ratio Rank: 5959
Omega Ratio Rank
^GSPC Calmar Ratio Rank: 5555
Calmar Ratio Rank
^GSPC Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CSPCY vs. ^GSPC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CSPC Pharmaceutical Group Limited (CSPCY) and S&P 500 Index (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CSPCY^GSPCDifference
Sharpe ratioReturn per unit of total volatility

-1.93

Sortino ratioReturn per unit of downside risk

-2.31

Omega ratioGain probability vs. loss probability

1.00

1.30

-0.30

Calmar ratioReturn relative to maximum drawdown

-0.36

2.29

-2.66

Martin ratioReturn relative to average drawdown

-0.68

10.15

-10.82

CSPCY vs. ^GSPC - Sharpe Ratio Comparison

The current CSPCY Sharpe Ratio is -0.26, which is lower than the ^GSPC Sharpe Ratio of 1.67. The chart below compares the historical Sharpe Ratios of CSPCY and ^GSPC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CSPCY vs. ^GSPC - Drawdown Comparison

The maximum CSPCY drawdown since its inception was -69.41%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for CSPCY and ^GSPC.


Loading charts...

Drawdown Indicators


CSPCY^GSPCDifference

Max Drawdown

Largest peak-to-trough decline

-69.41%

-56.78%

-12.63%

Max Drawdown (1Y)

Largest decline over 1 year

-39.17%

-9.10%

-30.07%

Max Drawdown (3Y)

Largest decline over 3 years

-39.17%

-18.90%

-20.27%

Max Drawdown (5Y)

Largest decline over 5 years

-58.98%

-25.43%

-33.55%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-37.86%

-3.31%

-34.55%

Average Drawdown

Average peak-to-trough decline

-34.55%

-10.71%

-23.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.81%

2.05%

+18.76%

Volatility

CSPCY vs. ^GSPC - Volatility Comparison

CSPC Pharmaceutical Group Limited (CSPCY) has a higher volatility of 14.44% compared to S&P 500 Index (^GSPC) at 4.87%. This indicates that CSPCY's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CSPCY^GSPCDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.44%

4.87%

+9.57%

Volatility (6M)

Calculated over the trailing 6-month period

37.83%

9.90%

+27.93%

Volatility (1Y)

Calculated over the trailing 1-year period

54.94%

12.54%

+42.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.16%

17.00%

+31.16%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

136.03%

18.08%

+117.95%

Frequently Asked Questions


CSPCY and ^GSPC have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CSPCY has higher volatility (14.44%) compared to ^GSPC (4.87%). In terms of maximum drawdown, CSPCY dropped -69.41% vs ^GSPC's -56.78%.

^GSPC currently has the higher Sharpe Ratio (1.67 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CSPCY and ^GSPC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer